alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.2

  CERTIFICATION OF CHIEF FINANCIAL OFFICER REGARDING PERIODIC REPORT CONTAINING
 FINANCIAL STATEMENTS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, C. Troy Woodbury,  Jr., the Chief  Financial  Officer of Wegener  Corporation
(the "Company"),  in compliance with 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the  Sarbanes-Oxley  Act of 2002,  hereby certify that, to the
best of my  knowledge,  the  Company's  Quarterly  Report  on Form  10-Q for the
quarter ended  November 28, 2003 (the  "Report")  filed with the  Securities and
Exchange Commission:

     o    fully complies with the  requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and

     o    the  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.


                                   /s/ C. Troy Woodbury, Jr.

                                   Name:  C. Troy Woodbury, Jr.
                                   Title: Treasurer and Chief Financial Officer
                                          (Principal Financial Officer)
                                   Date: January 12, 2004

<PAGE>
<TABLE> <S> <C>

<ARTICLE>  5
<LEGEND>

THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE FINANCIAL STATEMENTS OF BURR-BROWN CORPORATION FOR THE
NINE MONTHS ENDED OCTOBER 2, 1999

</LEGEND>

<MULTIPLIER>                   1,000
<S>                            <C>
<PERIOD-TYPE>                  9-MOS
<FISCAL-YEAR-END>              DEC-31-1999
<PERIOD-END>                   OCT-2-1999
<CASH>                         102,493
<SECURITIES>                   41,091
<RECEIVABLES>                  68,789
<ALLOWANCES>                   715
<INVENTORY>                    52,277
<CURRENT-ASSETS>               272,996
<PP&E>                         213,247
<DEPRECIATION>                 119,744
<TOTAL-ASSETS>                 376,315
<CURRENT-LIABILITIES>          62,180
<BONDS>                        0
<PREFERRED-MANDATORY>          0
<PREFERRED>                    0
<COMMON>                       391
<OTHER-SE>                     305,063
<TOTAL-LIABILITY-AND-EQUITY>   376,315
<SALES>                        207,254
<TOTAL-REVENUES>               207,254
<CGS>                          99,552
<TOTAL-COSTS>                  99,552
<OTHER-EXPENSES>               67,800
<LOSS-PROVISION>               (98)
<INTEREST-EXPENSE>             343
<INCOME-PRETAX>                41,872
<INCOME-TAX>                   11,307
<INCOME-CONTINUING>            30,565
<DISCONTINUED>                 0
<EXTRAORDINARY>                0
<CHANGES>                      0
<NET-INCOME>                   30,565
<EPS-BASIC>                    0.83
<EPS-DILUTED>                  0.79


</TABLE>
#### SGANLIN et al., Respondents, v. GIBSON, Appellant.

(Supreme Court, Appellate Divi•sion, Fourth Department.

March 20, 1912.)

Action by David Scanlin and another against Amelia C. Gibson.

PER CURIAM.

Judgment affirmed, without costs.

ROBSON, J., dissents.
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Methods and Application of Food Composition Laboratory: Beltsville, MD
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    About MAFCLSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us






MAFCL site pagesheadline bar About MAFCL
               AMR
               FNR
               FDC
               Database Resources
               Historic Documents
               SR11-SR28
               Proanthocyanidin
               Choline
               Fluoride
               Isoflavone
               Nutrient retention factors
               NFNAP
               Key Foods
               Retail Meats
               Monitoring Sodium
               Flavonoids
               Measurement Conversion Tables
               Glossary
               SR28 - Page Reports
               Beef Calculator
               SR Legacy Nutrient Search
               Cooking Yields
               Iodine
               Beef study: USDA Select and USDA Choice cuts
               Beef variety meat study
               Domestic Grass and Grain Finished Lamb
               Purine Content of Foods
               IngID Thesaurus


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2373 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 2373

     To suspend temporarily the duty on 2-chlorobenzenesulfonamide.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 16, 2005

 Mrs. Capito introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
     To suspend temporarily the duty on 2-chlorobenzenesulfonamide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2-CHLOROBENZENESULFONAMIDE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.09.05      2-                  Free         No change        No change        On or before 12/  ''.
                         chlorobenzenesulf                                                  31/2008
                         onamide (CAS No.
                         6961-82-6)
                         (provided for in
                         subheading
                         2935.00.75)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of enactment of this Act.
                                 <all>
```
EXHIBIT 31.2     CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002I, Tracy A. Kern, as Chief Financial Officer of CHAD Therapeutics, Inc. (the “registrant”), herebycertify that:(1) I have reviewed this quarterly report on Form 10-Q of CHAD Therapeutics, Inc.; (2) Based on my knowledge, this quarterly report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading with respect to theperiod covered by this quarterly report; (3) Based on my knowledge, the financial statements, and other financial information included inthis quarterly report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periods presentedin this quarterly report; (4) The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in which thisquarterly report is being prepared;  (b) Paragraph omitted;  (c) evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on suchevaluation; and  (d) disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and(5) The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions): (a) all significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  (b) any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.        Date: August 14, 2006 /s/ Tracy A. Kern   Tracy A. Kern        Chief Financial Officer of CHAD Therapeutics, Inc.
# Euroopan unionin C 87I/2022

| | ISSN 1977-1053 |
| --- | --- |
| Euroopan unionin
  virallinen lehti | C 087I |
| | |
| Suomenkielinen laitos | Tiedonantoja ja ilmoituksia | 65. vuosikerta23. helmikuu 2022 |

ISSN 1977-1053

Euroopan unionin

virallinen lehti

C 087I

Suomenkielinen laitos

Tiedonantoja ja ilmoituksia

65. vuosikerta23. helmikuu 2022

---

| Sisältö | Sivu |
| --- | --- |
| | IV   Tiedotteet |
| | EUROOPAN UNIONIN TOIMIELINTEN, ELINTEN, TOIMISTOJEN JA VIRASTOJEN TIEDOTTEET |
| | Euroopan komissio |
| 2022/C 87 I/01 | Ilmoitus tuojille – Tuonti unioniin EU:n ja Ukrainan assosiaatiosopimuksen nojalla muilta kuin Ukrainan hallituksen hallinnassa olevilta Donetskin ja Luhanskin alueilta | 1 |

Sisältö

Sivu

IV   Tiedotteet

EUROOPAN UNIONIN TOIMIELINTEN, ELINTEN, TOIMISTOJEN JA VIRASTOJEN TIEDOTTEET

Euroopan komissio

2022/C 87 I/01

Ilmoitus tuojille – Tuonti unioniin EU:n ja Ukrainan assosiaatiosopimuksen nojalla muilta kuin Ukrainan hallituksen hallinnassa olevilta Donetskin ja Luhanskin alueilta

1

---

| FI | |
| --- | --- |

FI

---

IV Tiedotteet

EUROOPAN UNIONIN TOIMIELINTEN, ELINTEN, TOIMISTOJEN JA VIRASTOJEN TIEDOTTEET

Euroopan komissio

| 23.2.2022 | FI | Euroopan unionin virallinen lehti | CI 87/1 |
| --- | --- | --- | --- |

23.2.2022

FI

Euroopan unionin virallinen lehti

CI 87/1

---

Ilmoitus tuojille

Tuonti unioniin EU:n ja Ukrainan assosiaatiosopimuksen nojalla muilta kuin Ukrainan hallituksen hallinnassa olevilta Donetskin ja Luhanskin alueilta

(2022/C 87 I/01)

Euroopan komissio ilmoittaa tuojille, että Ukrainan tulliviranomaisilla ei ole tarvittavia edellytyksiä hallinnoida ja valvoa tehokkaasti Euroopan unionin ja sen jäsenvaltioiden sekä Ukrainan välillä tehdyssä assosiaatiosopimuksessa määrättyä tullietuuskohtelua sellaisten tavaroiden osalta, jotka on tuotettu muilla kuin Ukrainan hallituksen hallinnassa olevilla Donetskin ja Luhanskin alueilla tai jotka viedään kyseisiltä alueilta.

Koska Ukrainan tulliviranomaisilla ei ole mahdollisuutta soveltaa sopimuksen asiaankuuluvia määräyksiä sen takaamiseksi, että kyseisiltä alueilta tulevat tavarat ovat oikeutettuja tullietuuskohteluun, eikä tarkistaa, että ne täyttävät kaikki tarvittavat vaatimukset, joista määrätään erityisesti assosiaatiosopimuksen pöytäkirjassa 1 olevassa 33 artiklassa, edellytykset tullietuuskohtelun myöntämiseksi tällaisille tavaroille eivät täyty.

Euroopan unionin toimijoita kehotetaan sen vuoksi olemaan hakematta tullietuuskohtelua kaikille sellaisille unioniin tuotaville tavaroille, jotka on tuotettu muilla kuin Ukrainan hallituksen hallinnassa olevilla Donetskin ja Luhanskin alueilla tai jotka viedään kyseisiltä alueilta, koska näiden tavaroiden luovuttaminen vapaaseen liikkeeseen aiheuttaa tullivelan tämän ilmoituksen julkaisemispäivästä alkaen.

---
EXHIBIT 23.1



CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-108719 and 333-118922) and Form S-8
(Nos. 333-90950, 333-109058 and 333-116589) of Advanced Medical Optics, Inc. of our report dated February 28, 2005 relating to the financial statements, financial statement schedule, managements assessment of the effectiveness of internal
control over financial reporting and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.



|                              
|------------------------------
|/s/ PricewaterhouseCoopers LLP
|Orange County, California     

March 1, 2005
EXHIBIT 99.2


March 27, 2003



Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549


WRITTEN STATEMENT OF THE CHIEF FINANCIAL OFFICER ACCOMPANYING
REPORT ON FORM 10-K OF VERIZON WIRELESS OF THE EAST LP
(THE "PARTNERSHIP") FOR THE YEAR ENDING DECEMBER 31, 2002

I, Andrew N. Halford, Vice President and Chief Financial Officer of Cellco
Partnership, which is the sole member of Verizon Wireless of Georgia LLC, the
managing general partner of the Partnership, certify that:

(1)  the report of the Partnership on Form 10-K for the year ending December
     31, 2002 (the "Report") fully complies with the requirements of section
     15(d) of the Securities Exchange Act of 1934; and

(2)  the information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the
     Partnership as of the dates and for the periods presented in the Report.

This statement is being provided pursuant to section 1350 of chapter 63 of
title 18 of the United States Code.


/s/ Andrew N. Halford
------------------------
Andrew N. Halford



A signed original of this written statement required by Section 906 has been
provided to Verizon Wireless of the East LP and will be retained by Verizon
Wireless of the East LP and furnished to the Securities and Exchange Commission
or its staff upon request.

This certification is being submitted to the Securities and Exchange Commission
solely for the purpose of complying with Section 1350 of Chapter 63 of Title 18
of the United States Code. This certification shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liability of that section. This certification does not
constitute a part of Verizon Wireless of the East LP's Annual Report on Form
10-K accompanying this certification and to which it is an exhibit.
[Federal Register Volume 86, Number 123 (Wednesday, June 30, 2021)]
[Presidential Documents]
[Page 34591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14072]




                        Presidential Documents 



Federal Register / Vol. 86, No. 123 / Wednesday, June 30, 2021 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 34591]]

                Memorandum of June 21, 2021

                
Delegation of Certain Authorities and Functions 
                Under Section 353 of the United States-Northern 
                Triangle Enhanced Engagement Act

                Memorandum for the Secretary of State

                By the authority vested in me as President by the 
                Constitution and the laws of the United States of 
                America, including section 301 of title 3, United 
                States Code, I hereby delegate to the Secretary of 
                State all authorities and functions vested in the 
                President by section 353 of the United States-Northern 
                Triangle Enhanced Engagement Act (Subtitle F of Title 
                III of Division FF of Public Law 116-260) (the 
                ``Act'').

                Any reference herein to the Act related to the subject 
                of this memorandum shall be deemed to include 
                references to any hereafter-enacted provisions of law 
                that are the same or substantially the same as such 
                provisions.

                You are authorized and directed to publish this 
                memorandum in the Federal Register.
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

                THE WHITE HOUSE,

                    Washington, June 21, 2021

[FR Doc. 2021-14072
Filed 6-29-21; 8:45 am]
Billing code 4710-10-P
Exhibit 31.2



CERTIFICATION



I, Elizabeth Schroeder, Chief Financial Officer of Wyndham International, Inc., certify that:



1. I have reviewed this quarterly report on Form 10-Q of Wyndham International, Inc.;



2. Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3. Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4. The registrants other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b) Evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c) Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially
affect, the registrants internal control over financial reporting; and



5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants
board of directors (or persons performing the equivalent functions):



(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and
report financial information; and



(b) Any fraud, whether or
not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.



|                       |  |        |  |                        
|---------------------- |  | ------ |  | -----------------------
|Date: November 9, 2004 |  | By:    |  | /s/ Elizabeth Schroeder
|                       |  | Name:  |  | Elizabeth Schroeder    
|                       |  | Title: |  | Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          55,983
<INT-BEARING-DEPOSITS>                             277
<FED-FUNDS-SOLD>                                10,700
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    150,731
<INVESTMENTS-CARRYING>                         189,328
<INVESTMENTS-MARKET>                           189,809
<LOANS>                                      1,141,052
<ALLOWANCE>                                      9,684
<TOTAL-ASSETS>                               1,552,889
<DEPOSITS>                                   1,348,962
<SHORT-TERM>                                    38,932
<LIABILITIES-OTHER>                              8,751
<LONG-TERM>                                     15,773
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        28,411
<OTHER-SE>                                     112,060
<TOTAL-LIABILITIES-AND-EQUITY>               1,552,889
<INTEREST-LOAN>                                 44,397
<INTEREST-INVEST>                               10,376
<INTEREST-OTHER>                                   269
<INTEREST-TOTAL>                                55,042
<INTEREST-DEPOSIT>                              21,138
<INTEREST-EXPENSE>                              22,775
<INTEREST-INCOME-NET>                           32,267
<LOAN-LOSSES>                                    2,090
<SECURITIES-GAINS>                                  21
<EXPENSE-OTHER>                                 23,283
<INCOME-PRETAX>                                 12,613
<INCOME-PRE-EXTRAORDINARY>                      12,613
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     8,276
<EPS-PRIMARY>                                     1.46
<EPS-DILUTED>                                     1.46
<YIELD-ACTUAL>                                    4.82
<LOANS-NON>                                      8,835
<LOANS-PAST>                                       477
<LOANS-TROUBLED>                                   316
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 9,681
<CHARGE-OFFS>                                    2,279
<RECOVERIES>                                       192
<ALLOWANCE-CLOSE>                                9,684
<ALLOWANCE-DOMESTIC>                             9,684
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>